Rinat Neuroscience
A leader in the development of therapeutic antibodies.
Launch date
Employees
Market cap
-
Enterprise valuation
$160—240m (Dealroom.co estimates Aug 2003.)
Palo Alto California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $17.5m | Series A | |
$40.0m | Series B | ||
N/A | N/A | - | |
N/A | Acquisition | ||
Total Funding | $57.5m |